Assessment of Regional Differences in Tariquidar-Induced P-Glycoprotein Modulation at the Human Blood–Brain Barrier
暂无分享,去创建一个
Friederike Neumann | Wolfgang Löscher | Oliver Langer | Rudolf Karch | Kurt Kletter | Martin Bauer | W. Löscher | M. Zeitlinger | O. Langer | R. Karch | F. Neumann | M. Bauer | Markus Müller | K. Kletter | Markus Müller | Markus Zeitlinger | Claudia C Wagner | C. Wagner
[1] W. Löscher,et al. Tariquidar-Induced P-Glycoprotein Inhibition at the Rat Blood–Brain Barrier Studied with (R)-11C-Verapamil and PET , 2008, Journal of Nuclear Medicine.
[2] Mark Lubberink,et al. Evaluation of Tracer Kinetic Models for Quantification of P-Glycoprotein Function using (R)-[11C]Verapamil and PET , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[3] Alexander Hammers,et al. Three‐dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe , 2003, Human brain mapping.
[4] D. Mankoff,et al. Imaging P‐glycoprotein Transport Activity at the Human Blood‐brain Barrier with Positron Emission Tomography , 2005, Clinical pharmacology and therapeutics.
[5] Wolfgang Löscher,et al. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases , 2005, Progress in Neurobiology.
[6] Rudie Kortekaas,et al. Blood–brain barrier P-glycoprotein function decreases in specific brain regions with aging: A possible role in progressive neurodegeneration , 2009, Neurobiology of Aging.
[7] P. Herscovitch,et al. P-Glycoprotein Function at the Blood–Brain Barrier Imaged Using 11C-N-Desmethyl-Loperamide in Monkeys , 2008, Journal of Nuclear Medicine.
[8] Stephan Kopp,et al. A Pilot Study to Assess the Efficacy of Tariquidar to Inhibit P-glycoprotein at the Human Blood–Brain Barrier with (R)-11C-Verapamil and PET , 2009, Journal of Nuclear Medicine.
[9] Alexander Hammers,et al. Pharmacoresistance in Epilepsy : A Pilot PET Study with the P-Glycoprotein Substrate R-[ 11 C ] verapamil ∗ † , 2007 .
[10] Elizabeth Fox,et al. Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor , 2007, Expert review of anticancer therapy.
[11] J Nucl Med , 2010 .
[12] M. Lubberink,et al. Peripheral metabolism of (R)-[11C]verapamil in epilepsy patients , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[13] Elizabeth C M de Lange,et al. Potential role of ABC transporters as a detoxification system at the blood-CSF barrier. , 2004, Advanced drug delivery reviews.
[14] W. Löscher,et al. Dose-response assessment of tariquidar and elacridar and regional quantification of P-glycoprotein inhibition at the rat blood-brain barrier using (R)-[11C]verapamil PET , 2010, European Journal of Nuclear Medicine and Molecular Imaging.